Green Cross, Samil to join forces in OTC products

Published: 2010-09-10 06:56:00

Updated: 2010-09-10 06:56:00

Green Cross Corp. and Samil Pharm have agreed to join hands to market Samil’s Tiersilonce (terbinafine), a potent athlete’s foot treatment and artificial tear solution EYE2O, it was learned on September 5.

Tiersilonce is a synthetic allylamine antifungal with better permeation into skin and is...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK